PANZYGA 100 mg/ml, solution for infusion bottle, 300 ml
Active ingredients: IMMUNOGLOBULINE HUMAINE NORMALE (PLASMATIQUE)
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for infusionbottle, 300 mlintraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- PANZYGA 100 mg/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 300 ml
- Marketing authorisation holder
- OCTAPHARMA FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60616687CIP75502157CIP133400955021575Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMMUNOGLOBULINE HUMAINE NORMALE (PLASMATIQUE)solution | 100 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.